- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Safety of Apixaban for Cancer-Associated Thrombosis ; volume:121 ; number:05 ; year:2021 ; pages:547-551
Thrombosis and haemostasis ; 121, Heft 05 (2021), 547-551
- Contributor
-
Bikdeli, Behnood
Jiménez, David
- DOI
-
10.1055/a-1367-7830
- URN
-
urn:nbn:de:101:1-2021060812501771164641
- Rights
-
Kein Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bikdeli, Behnood
- Jiménez, David
Other Objects (12)
Cancer-associated thrombosis in Asia
Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
Erratum: Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
Therapeutic Shifts in the Management of Cancer-Associated Thrombosis
Challenging Situations in the Treatment of Cancer-Associated Thrombosis
Management of Cancer-Associated Thrombosis: Unmet Needs and Future Perspectives
Proper application of anticoagulation therapy on cancer-associated venous thrombosis
NETosis: A New Factor in Tumor Progression and Cancer-Associated Thrombosis
Clinical outcomes of cancer-associated isolated superficial vein thrombosis in daily practice
Management of Cancer-Associated Venous Thrombosis: A Nationwide Survey among Danish Oncologists
Rivaroxaban versus Apixaban for Treatment of Cancer-Associated Venous Thromboembolism in Patients at Lower Risk of Bleeding
Clinical trial assessing the safety of edoxaban with concomitant chemotherapy in patients with gynecological cancer-associated thrombosis (EGCAT study)
Cancer-associated thrombosis in Asia
Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
Erratum: Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
Therapeutic Shifts in the Management of Cancer-Associated Thrombosis
Challenging Situations in the Treatment of Cancer-Associated Thrombosis
Management of Cancer-Associated Thrombosis: Unmet Needs and Future Perspectives
Proper application of anticoagulation therapy on cancer-associated venous thrombosis
NETosis: A New Factor in Tumor Progression and Cancer-Associated Thrombosis
Clinical outcomes of cancer-associated isolated superficial vein thrombosis in daily practice
Management of Cancer-Associated Venous Thrombosis: A Nationwide Survey among Danish Oncologists
Rivaroxaban versus Apixaban for Treatment of Cancer-Associated Venous Thromboembolism in Patients at Lower Risk of Bleeding
Clinical trial assessing the safety of edoxaban with concomitant chemotherapy in patients with gynecological cancer-associated thrombosis (EGCAT study)
Cancer-associated thrombosis in Asia
Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
Erratum: Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
Therapeutic Shifts in the Management of Cancer-Associated Thrombosis
Challenging Situations in the Treatment of Cancer-Associated Thrombosis
Management of Cancer-Associated Thrombosis: Unmet Needs and Future Perspectives
Proper application of anticoagulation therapy on cancer-associated venous thrombosis
NETosis: A New Factor in Tumor Progression and Cancer-Associated Thrombosis
Clinical outcomes of cancer-associated isolated superficial vein thrombosis in daily practice
Management of Cancer-Associated Venous Thrombosis: A Nationwide Survey among Danish Oncologists
Rivaroxaban versus Apixaban for Treatment of Cancer-Associated Venous Thromboembolism in Patients at Lower Risk of Bleeding